Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

Disease:

BARD1 Gene Mutation;BRCA1 Gene Mutation;BRCA2 Gene Mutation;BRIP1 Gene Mutation;Estrogen Receptor Negative;HER2/Neu Negative;MLH1 Gene Mutation;MSH2 Gene Mutation;MSH6 Gene Mutation;PALB2 Gene Mutation;PMS2 Gene Mutation;Progesterone Receptor Negative;RAD51C Gene Mutation;RAD51D Gene Mutation;Triple-Negative Breast Carcinoma

Study phase:

Not applicable

Physician name:

Roni Wilke

Department:

Gynecologic Oncology & Reproductive Medicine

For general questions about clinical trials:

1-877-632-6789